跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PAXNEURY 5 MG COMPRIMIDOS DE LIBERACION PROLONGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PAXNEURY 5 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Approved
STANDARD
PAXNEURY 5 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Neuraxpharm Pharmaceuticals S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 19, 2025
Approval ID
2d5a253ee31e8157
Company
Neuraxpharm Pharmaceuticals S.L.
Type
Standard
Approval Details
Approval Id
2d5a253ee31e8157
Drug Cima Aemps Name
PAXNEURY 5 MG COMPRIMIDOS DE LIBERACION PROLONGADA
Register Number
1241908005
Holder Company Name
Neuraxpharm Pharmaceuticals S.L.
Marketing Company Name
Neuraxpharm Spain S.L.U.
Holder Company Detail Path
/organization/neuraxpharm-pharmaceuticals-s-l
Authorization Date
2025-03-19
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Neuraxpharm Pharmaceuticals S.L.
Company Detail Path
/organization/neuraxpharm-pharmaceuticals-s-l
Company Information
Pharmaceutical Company Name
NEURAXPHARM PHARMACEUTICALS S.L.
Country Name
Spain
City Name
sant joan despi,barcelona,country_es
Address
AVENIDA BARCELONA 69
Active Ingredients
GUANFACINA HIDROCLORURO
5,740 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 19, 2025
Approval ID
2d5a253ee31e8157
Type
Standard
Back to CIMA-AEMPS Approvals
